| BSE: 532660 | Sector: Health care |
| NSE: VIVIMEDLAB | ISIN Code: INE526G01021 |
| BSE 00:00 | 12 Dec | 38.95 |
3.05 (8.50%) |
OPEN
36.45 |
HIGH
39.70 |
LOW
36.45 |
| NSE 00:00 | 12 Dec | 38.90 |
2.85 (7.91%) |
OPEN
36.45 |
HIGH
39.90 |
LOW
36.35 |
| OPEN | 36.45 |
| PREVIOUS CLOSE | 35.90 |
| VOLUME | 40198 |
| 52-Week high | 117.80 |
| 52-Week low | 34.50 |
| P/E | 35.73 |
| Mkt Cap.(Rs cr) | 321 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Vivimed Labs Ltd is engaged in manufacturing of Specialty Chemicals (mainly used in Personal Care and Cosmetic Industry), Pharmaceuticals, API's and Formulations. The company has strong presence in the areas of Health & Personal Care, Contract Research and Manufacturing. The company has four subsidiary companies, namely Creative Health Care Pvt Ltd, Vivimed Holdings Ltd (Hong Kong), Vivimed Labs E...> More
| Parameter | Values | ||
| Market Cap | ( cr) |
321 | |
| EPS - TTM | () |
[*S] | 1.09 |
| P/E Ratio | (X) | [*S] | 35.73 |
| Face Value | () |
2 | |
| Latest Dividend | (%) | 20.00 | |
| Latest Dividend Date | 19 Sep 2018 | ||
| Dividend Yield | (%) | 1.03 | |
| Book Value / Share | () |
[*S] | 64.85 |
| P/B Ratio | () |
[*S] | 0.60 |
Announcement under Regulation 30 (LODR)-Investor Presentation
Outcome Of The Meeting Of The Board Of Directors Of The Company
Board Meeting Intimation for Notice Of Board Meeting For Considering Unaudited Financial Results For
Compliance Certificate Under Regulation 7(3) Of The SEBI (Listing Obligations And Disclosure Require
Particulars ( cr) |
Sep 2018 | Sep 2017 | % Chg |
| Net Sales | 364.62 | 282.5 | 29.07 |
| Other Income | 5.04 | 0.61 | 726.23 |
| Total Income | 369.66 | 283.11 | 30.57 |
| Total Expenses | 314.42 | 219.9 | 42.98 |
| Operating Profit | 55.24 | 63.22 | -12.62 |
| Net Profit | 18.28 | 22.07 | -17.17 |
| Equity Capital | 16.5 | 16.4 | - |
| Company | Price() |
Chg (%) | Mkt Cap ( CR) |
| Lincoln Pharma. | 228.15 | 2.84 | 456.30 |
| RPG LifeScience. | 250.45 | 5.21 | 414.18 |
| Anuh Pharma | 150.05 | -1.44 | 376.03 |
| Vivimed Labs. | 38.95 | 8.50 | 321.34 |
| Themis Medicare | 330.00 | -1.62 | 302.94 |
| NGL Fine Chem | 448.65 | 0.56 | 277.27 |
| Jenburkt Pharma | 568.95 | 0.08 | 261.15 |
|
|
|
| Period | BSE | NSE | Sensex | NIFTY |
| 1 Week | 4.01% | 2.91% | -0.29% | -0.42% |
| 1 Month | 0.65% | 0.91% | 2.78% | 2.44% |
| 3 Month | -34.54% | -35.17% | -5.14% | -5.56% |
| 6 Month | -34.81% | -35.00% | 0.24% | -0.97% |
| 1 Year | -66.10% | -66.17% | 7.68% | 4.86% |
| 3 Year | -49.92% | -49.90% | 42.86% | 41.09% |
| Today's Low/High | 36.45 |
|
39.70 |
| Week Low/High | 35.30 |
|
39.70 |
| Month Low/High | 35.30 |
|
44.00 |
| YEAR Low/High | 34.50 |
|
118.00 |
| All TIME Low/High | 6.44 |
|
153.00 |
Promoters
Banks/FIs
FIIs
Insurance
Mutual Funds
Indian Public
Custodians
Other
